439 related articles for article (PubMed ID: 10367819)
1. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
2. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
[TBL] [Abstract][Full Text] [Related]
4. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in relation to breast cancer.
Chen CL; Weiss NS; Newcomb P; Barlow W; White E
JAMA; 2002 Feb; 287(6):734-41. PubMed ID: 11851540
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.
Calle EE; Feigelson HS; Hildebrand JS; Teras LR; Thun MJ; Rodriguez C
Cancer; 2009 Mar; 115(5):936-45. PubMed ID: 19156895
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI; Anderson BO; Daling JR; Moe RE
JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
[TBL] [Abstract][Full Text] [Related]
10. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
11. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
13. Effects of menopausal hormone therapy on ductal carcinoma in situ of the breast.
Luo J; Cochrane BB; Wactawski-Wende J; Hunt JR; Ockene JK; Margolis KL
Breast Cancer Res Treat; 2013 Feb; 137(3):915-25. PubMed ID: 23315265
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement and breast cancer: implications of the Iowa Women's Health Study.
Mayer ME
Cleve Clin J Med; 1999; 66(10):608-10, 613. PubMed ID: 10598365
[TBL] [Abstract][Full Text] [Related]
15. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer.
Ravdin PM
Breast Dis; 2008-2009; 30():3-8. PubMed ID: 19850989
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon A; Freedman G; Patchefsky A; Kessler H; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Goldstein L
J Clin Oncol; 1999 Jun; 17(6):1680-8. PubMed ID: 10561204
[TBL] [Abstract][Full Text] [Related]
18. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR
Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
[TBL] [Abstract][Full Text] [Related]
20. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
Reeves GK; Beral V; Green J; Gathani T; Bull D;
Lancet Oncol; 2006 Nov; 7(11):910-8. PubMed ID: 17081916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
